Macrocyclic EGFR Inhibitor, and Preparation Method Therefor and Pharmaceutical Use Thereof
AssigneeAbbisko Therapeutics Co., Ltd.
InventorsFei YANG, Haibing DENG, Yong YU, Hongping YU, Zhui CHEN, Yaochang XU
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbisko Therapeutics Co., Ltd.
InventorsFei YANG, Haibing DENG, Yong YU, Hongping YU, Zhui CHEN, Yaochang XU
Estimating the term…
The present invention relates to a macrocyclic EGFR inhibitor and preparation method therefor and pharmaceutical use thereof. In particular, the present invention relates to an EGFR inhibitor having a structure of formula (I), a pharmaceutical composition thereof, a use thereof as an EGFR inhibitor, and a use thereof in the preparation of a drug for treating and/or preventing tumors or metastatic diseases associated at least partially with EGFR L858R/C797S double mutation, EGFR Del19/C797S double mutation, L858R/T790M/C797S triple mutation and Del19/T790M/C797S triple mutation, especially in the preparation of a drug for treating and/or preventing hyperproliferative diseases and disorders inducing cell death. Each substituent of formula (I) is as defined in the description.
A compound of formula (I), or a stereoisomer or pharmaceutically acceptable salt thereof:
(canceled)
Dependencies are inferred from the claim text.